PIK3CA is frequently mutated in several types of cancers [13], and notably, several disorders characterized by skeletal and soft tissue overgrowth have been grouped under the term PIK3CA-related overgrowth spectrum (PROS) due to the presence of somatic PIK3CA mutations. The gene discussed is PIK3CA; the disease is cancer.